Ringholm, Lene
Roskjær, Ann B.
Engberg, Susanne
Andersen, Henrik U.
Secher, Anna L.
Damm, Peter
Mathiesen, Elisabeth R.
Article History
Received: 25 May 2018
Accepted: 26 November 2018
First Online: 3 January 2019
Duality of interest
: HUA owns stocks in Novo Nordisk A/S and participates in advisory boards for AstraZeneca and Novo Nordisk A/S. PD and ERM are participating in multicentre and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. PD and ERM are in the speaker’s bureau of Novo Nordisk. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.